Skip to main content

and
  1. No Access

    Protocol

    Radiosynthesis of [18F]FPenM-C2Am: A PET Imaging Agent for Detecting Cell Death

    Imaging agents capable of detecting the extent, timing, and distribution of tumor cell death following treatment could be used in clinical trials of novel cancer therapies to get an early indication of efficac...

    Flaviu Bulat, André A. A. Neves, Kevin M. Brindle in Positron Emission Tomography (2024)

  2. Article

    Open Access

    18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography

    Trialing novel cancer therapies in the clinic would benefit from imaging agents that can detect early evidence of treatment response. The timing, extent and distribution of cell death in tumors following treat...

    Flaviu Bulat, Friederike Hesse, De-En Hu, Susana Ros in EJNMMI Research (2020)